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INTRODUCTION
FDG PET/CT (positron emission tomography/
computer tomography with fluorodesoxyglucose) 
is an essential imaging modality in staging and 
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treatment response assessment as well as a powerful 
prognostic tool in various types of lymphomas 
with Hodgkin’s lymphoma (НD) being the primary 
indication (5). FDG accumulation represents the 
glucose utilization that is generally increased in 
malignant tumors. Unfortunately, the nature of the 
radiopharmaceutical - fluorinated desoxiglucose 
makes it quite an unspecific marker. The potential 
causes of high glucose/respectively FDG utilization, 
apart from malignant tumors are numerous (1,7,8). 
The most common concern remains inflammation, 
although nonspecific inflammatory changes present 
with less prominent activity and in case of cautious 
ABSTRACT
FDG-PET is an essential diagnostic tool in the management of Hodgkin’s lymphoma (HD). However, a lot 
of benign conditions are well-known to present with high FDG uptake thus mimicking malignant activity. 
Tuberculosis (TBC) is an infection with known high FDG accumulation and should be suspected in patients 
with lymphoma and those treated with chemotherapy.
CASE REPORT: We present a 19-year old female with mediastinal Hodgkin’s lymphoma who had discrete 
lung changes on presentation. After initial chemotherapy, patient’s status worsened, with CT scan showing 
complete resolution of the mediastinal mass along with progression in the lung. Patient was restaged and 
mediastinal and lung involvement was proven. Therapy was escalated with further worsening and newly-
found liver lesions. TBC was clinically suspected although not objectively proven. FDG PET scan revealed 
high activity infiltrative lung changes, diffuse pleural activity, active liver lesions and celiac lymph nodes. 
However, changes could not be addressed as malignant, due to TBC or to both. Pleural biopsy revealed TBC. 
Patient received anti-TBC treatment only. The follow-up FDG PET scan revealed almost complete resolution 
of all the changes consistent with complete remission of the lymphoma and good treatment response of TBC.
CONCLUSION: Based on initial CT report we consider this case a coexistence of TBC and HD at initial pre-
sentation with further worsening rather than a newly-developed TBC on an immunosupressed ground. FDG 
PET is an excellent tool in HD management, but falsely positive results from TBC should be kept in mind, 
especially when lung in involved.
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interpretation their role as a potential pitfall is 
overrated. This cannot be directly addressed to 
granulomatous inflammation such as tuberculosis 
(TBC) and to specific granulomatous diseases such 
as sarcoidosis. Their activity could be very high and 
definitely indistinguishable from malignancy (1-3,6-
8). Adequate FDG PET/CT reading can only be made 
in the context of the overall patient’s data, including 
clinical, imaging, laboratory data, etc.
CASE REPORT
We hereby present a case of a 19-year old female 
with Hodgkin’s lymphoma with primary mediastinal 
location. The patient’s first visit was due to persistent 
dry cough. The chest x-ray revealed mediastinal 
mass with lymphoma being the primary differential 
diagnosis. The patient was staged clinically and with 
conventional imaging methods. The initial staging 
CT (12/2009) revealed mediastinal mass as a primary 
finding, but noted discrete circumscribed  infiltrative/
fibrotic changes in the upper lobe of the right lung. 
Biopsy from the mediastinal mass was obtained by 
video-assisted thoracoscopy (VATS) with a result 
of sclero-nodular form of Hodgkin’s lymphoma 
(confirmed by immunohistochemistry, too). The 
patient was referred for a first-line chemotherapy 
with initial improvement of the symptoms and 
laboratory tests. After three ABVD cycles (from 
01/2010), patient’s status worsened with CT scan 
showing complete resolution of the mediastinal 
mass along with progression of the changes in the 
lung with further enlargement of the infiltrate and 
initial abscess formation. The patient was restaged 
and upstaged as being with mediastinal and lung 
involvement (stage IVB). Therapy was escalated 
to BEACOPP with further worsening and newly-
found liver lesions. The symptoms of cough, dispnea, 
febrility, night sweating and overall fatigue despite 
adequate treatment received for the initial diagnosis 
raised clinical suspicions of TBC, however, the results 
from the laboratory tests and sputum provided no 
proof of that. An FDG PET scan was scheduled after 
two cycles of BEACOPP chemotherapy. PET/CT was 
performed on a Phillips Gemini TF PET/CT as a 
standard whole body technique after initial patient 
preparation, overnight fasting and refrain from 
tobacco and alkaloid drinks, creatinine and blood 
glucose testing. The patient had been administered 
0,13 mCi/kg FDG and was scanned after 60 min 
uptake period. The FDG scan revealed high activity 
infiltrative lung changes, diffuse pleural activity, 
active liver lesions and celiac lymph nodes (Fig. 1). 
These findings could be addressed either to lymphoma 
(node involvement, hepatic activity), or to TBC (lung 
activity and, especially, the pattern of diffuse pleural 
involvement), or to both. The conclusion, however, 
was equivocal, with TBC being the main concern and 
the pleural involvement being the major pathology 
requiring treatment. Chemotherapy was ceased and 
tuberculostatic treatment was initiated. Excision 
pleural biopsy revealed TBC. Patient’s clinical status 
rapidly improved. The follow-up FDG PET scan 
Fig. 1. Restaging FDG PET/CT reveals extremely high 
diffuse bilateral pleural activity as well as activity in the 
lungs, celiac lymph nodes and several foci of liver uptake
Fig. 2. Follow-up FDG PET/CT reveals almost complete 
normalization of the activity in the pleura, lymph nodes 
and liver. The lung activity is almost cleared with small 
foci of moderate residual uptake in the right upper lobe
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(06/2010) revealed almost complete resolution of any 
changes consistent with complete remission of HD 
and good treatment response of TBC (Fig. 2).
DISCUSSION
In this case we emphasize the coexistence of 
two FDG avid conditions such as TBC and Hodgkin’s 
lymphoma which are hardly differentiated either 
clinically or by imaging. Lung damage is not a common 
but possible site of involvement in lymphoma and the 
findings on CT could mimic other benign conditions 
such as inflammatory infiltrates and TBC. Thus CT 
diagnosis is not definite (4). Neither is FDG PET/CT 
due to the fact that TBC results in an inflammation 
with extremely high glucose consumption and is 
indistinguishable from malignancy. The Reed-
Sternberg (RS) cells represent a small part of the 
lymph node pathology with lymphocyte infiltration 
being the major cell population in HD. Accumulation 
in RS cells alone can’t explain the invariably high 
HD FDG avidity. This activity could be addressed 
to the lymphocyte population that is present in TBC 
granuloma, too. On the other hand, lymphoma 
as is and its chemotherapeutic treatment suppress 
immune response and make a room for opportunistic 
infections such as TBC (3,4).
In this case we believe the lung TBC was 
preexisting (staging CT findings were not reported as 
suspicious for TBC but they did not exclude it, too). 
The fact that the abscess formation started at the site 
of the initial infiltrate also leads to that conclusion. 
During the course of the disease we detected 
discordant changes in the primary lymphoma mass 
in the mediastinum, which disappeared after three 
cycles of chemotherapy and the lung alterations 
that worsened. A misleading clue in the initial PET/
CT scan was the liver and celiac node involvement, 
which could be addressed to HD, but can be present 
in disseminated TBC, too (6). We found this case 
edifying in decision making based on overall patient’s 
data, rather than differential diagnosis alone because 
no test in this case was able to discriminate both 
conditions due to their  concomitant presentation.
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